Effectiveness of Spot-on ™ to Prevent Inadvertent Perioperative Hypothermia and Their Consecuences

Sponsor
Osakidetza (Other)
Overall Status
Unknown status
CT.gov ID
NCT02511080
Collaborator
(none)
70
1
2
29
2.4

Study Details

Study Description

Brief Summary

Using the spot-on device for monitoring core body temperature during colon laparoscopic surgery and prevent non-therapeutic hypothermia.

Condition or Disease Intervention/Treatment Phase
  • Device: Spot-On
N/A

Detailed Description

Take active measures to prevent non-therapeutic hypothermia during the laparoscopic colon surgery. We improve these measures using heat conductive air warm blankets placed under and o over the patient.

Perform monitoring core body temperature every 15 minutes by spot-on device compared with standard nasopharyngeal probe.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
70 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Prevention
Official Title:
Effectiveness of Spot-on ™ to Prevent Inadvertent Perioperative Hypothermia and Their Consecuences
Study Start Date :
Jul 1, 2016
Anticipated Primary Completion Date :
Jul 1, 2017
Anticipated Study Completion Date :
Dec 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Spot-on group

Use active measures against intraoperative hypothermia

Device: Spot-On
use of active hot measures

No Intervention: control

standard measures against intraoperative hipothermia

Outcome Measures

Primary Outcome Measures

  1. change in the Body Core Temperature [measure every 15 minutes since the patient arrive to operating room until is derivated to recovery room, an average of 3 hours]

    measure the body core temperature by Spoton device when the patient arrive to operating room

Secondary Outcome Measures

  1. incidence of blood transfusion [In the first two weeks after being operated.]

    Transfusion if hemoglobin lower than 7 mgr/dl

  2. surgical wound infection [while the patient stay in the hospital, an average of two weeks]

    the surgeon determines the infection of the surgical wound

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • All patients that need a colorrectal laparoscopic surgery
Exclusion Criteria:
  • Use of antagonist of Calcium

  • Alergy to medications

  • History of Malignant Hipertemia

  • Laparosocopy surgery ≥ 120 min

  • Temperature previous surgery over 38ºC

  • Taking chronic steroids

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hospital de Galdakao Galdakao Vizcaya Spain 48960

Sponsors and Collaborators

  • Osakidetza

Investigators

  • Principal Investigator: unai ortega, Osakidetza

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Unai Ortega Mera, Doctor, Osakidetza
ClinicalTrials.gov Identifier:
NCT02511080
Other Study ID Numbers:
  • CEIC 16/2015
First Posted:
Jul 29, 2015
Last Update Posted:
Sep 27, 2016
Last Verified:
Aug 1, 2015
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Keywords provided by Unai Ortega Mera, Doctor, Osakidetza
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 27, 2016